Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Technology to blueprint infectious diseases developed at Antex

June 14, 2000

OSI crosslicenses gene transcription patent estate with Merck

June 13, 2000

ARGENT + Dimerizer Drugs results in sustained production of EPO in monkeys

June 13, 2000

Basel Institute for Immunology to become a center for medical genomics with Roche support

June 9, 2000

TAP and IPF PharmaCeuticals enter research collaboration

June 9, 2000

Sangamo and R.W. Johnson establish collaborative research program

June 7, 2000

Daiichi licenses Captisol technology from CyDex

June 7, 2000

deCODE Genetics establishes research agreement with Partners

June 7, 2000

MorphoSys enters HuCAL agreements with Genentech and ProChon Biotech

June 6, 2000

Medarex and Biosite establish drug research alliance

June 5, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...